<DOC>
	<DOCNO>NCT00021502</DOCNO>
	<brief_summary>To determine safety effectiveness pyridoxylated hemoglobin polyoxyethylene conjugate ( PHP ) administer continuous intravenous ( IV ) infusion systemic inflammatory response syndrome ( SIRS ) patient shock . PHP human-derived chemically modify hemoglobin preparation . PHP selectively scavenge excess nitric oxide ( NO ) catalytic , concentration-dependent reaction result formation non-toxic NO metabolite , nitrate . PHP postulate reduce excess , toxic level NO allow critical beneficial level molecule persist .</brief_summary>
	<brief_title>Safety Efficacy PHP Treatment Shock Associated With Systemic Inflammatory Response Syndrome ( SIRS )</brief_title>
	<detailed_description>This Phase 3 , randomize , placebo control , multi-center study design evaluate safety efficacy continuous IV infusion PHP plus conventional vasopressor treatment , compare continuous IV infusion Plasma-Lyte A plus conventional vasopressor , treatment restore hemodynamic stability SIRS patient shock . Conventional vasopressor include dopamine &gt; 5 mcg/kg/min ; norepinephrine , phenylephrine epinephrine dose . The study consist Screening period , Pre-Treatment period , 28-day Treatment period . Efficacy determine evaluate objective clinical measure mortality organ function 28-day treatment period . The safety tolerability PHP evaluate continuous 28 day use number measure include evaluation : - cause mortality , - median patient survival time - adverse event rate duration .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<criteria>Determination study eligibility make Investigator basis inclusion criterion list : SIRS Inclusion Criteria Patients SIRS characterize two follow condition ( bad value 24 hour period ) : Either respiratory rate &gt; /= 20 breaths/minute , partial pressure arterial carbon dioxide ( PaCO2 ) &lt; /= 32 torr , mechanical ventilation , Heart rate &gt; /= 90 beats/minute , Either hyperthermia &gt; /= 38 degree C , hypothermia &lt; /= 36 degree C Either white blood cell ( WBC ) &gt; /= 12,000 cells/mm3 , &lt; /= 4,000 cells/mm3 , &gt; /= 10 % immature ( band ) form Shock Inclusion Criteria Patients adequate fluid resuscitation ( PCWP &gt; /= 12mmHg ) one conventional vasopressor ( continue time randomization ) use treat hypotension ( MBP &lt; 60 mmHg SBP &lt; 90 mmHg ) . Patients enter shock 24 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Pyridoxalated hemoglobin polyoxyethylene conjugate ( PHP )</keyword>
	<keyword>Systemic Inflammatory Response Syndrome ( SIRS )</keyword>
	<keyword>Nitric oxide ( NO )</keyword>
	<keyword>Shock</keyword>
</DOC>